Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer

Completed

Conditions studied: Hereditary Breast and Ovarian Cancer

In brief

The purpose of this study is to identify the most effective means of follow-up for women who screen positive on B-RST (Breast Cancer Genetics Referral Screening Tool) applied in the standard clinical setting of mammography, to maximize the number who are referred to and receive cancer genetic counseling services. The clinical utility of B-RST 3.0 will also be evaluated by determining the number seen who are appropriate for genetic testing, undergo genetic testing and are found to carry a hereditary cancer gene mutations with medical management implications for the patient and family. The long-term goal is to reduce the morbidity and mortality associated with hereditary causes of breast and ovarian cancer among patients seen in the Emory/Winship system.

Key facts

Study ID

NCT02786147

Run by

Emory University

People needed

665

Starts

2016-04-01

Expected to finish

2018-02-28

Last updated by the study team

2018-04-20

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Patient at one of the participating clinics (Winship Cancer Institute and Emory University Hospital Midtown) who arrive for a screening mammogram appointment.

You may not qualify if…

• Patients receiving a diagnostic mammogram will not be invited to participate in the study.

Where it is running

• Emory University Hospital Midtown — Atlanta, Georgia, United States
• Winship Cancer Institute — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.